Rosiglitazone-associated pseudotumour cerebri [1]

S. Dagdelen; O. Gedik

doi:10.1007/s00125-005-0055-9

Rosiglitazone-associated pseudotumour cerebri [1]

S. Dagdelen
, O. Gedik

Division of Internal Medicine (Medicine)

Hacettepe University

Research output: Contribution to journal › Letter › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	207-208
Number of pages	2
Journal	Diabetologia
Volume	49
Issue number	1
DOIs	https://doi.org/10.1007/s00125-005-0055-9
Publication status	Published - Jan 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s00125-005-0055-9

Cite this

@article{0d03ce71c7e74f96a66a1c3b264c8fae,

title = "Rosiglitazone-associated pseudotumour cerebri [1]",

author = "S. Dagdelen and O. Gedik",

year = "2006",

month = jan,

doi = "10.1007/s00125-005-0055-9",

language = "English",

volume = "49",

pages = "207--208",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

TY - JOUR

T1 - Rosiglitazone-associated pseudotumour cerebri [1]

AU - Dagdelen, S.

AU - Gedik, O.

PY - 2006/1

Y1 - 2006/1

UR - https://www.scopus.com/pages/publications/31444443852

U2 - 10.1007/s00125-005-0055-9

DO - 10.1007/s00125-005-0055-9

M3 - Letter

C2 - 16344924

AN - SCOPUS:31444443852

SN - 0012-186X

VL - 49

SP - 207

EP - 208

JO - Diabetologia

JF - Diabetologia

IS - 1

ER -

Rosiglitazone-associated pseudotumour cerebri [1]

UN SDGs

Access to Document

Other files and links

Cite this